A multicenter phase II trial of bortezomib in patients with previously untreated multiple myeloma: Efficacy with manageable toxicity in patients with unexpectedly high rates of baseline peripheral neuropathy Meeting Abstract
| Authors: | Richardson, P.; Chanan-Khan, A.; Schlossman, R.; Munshi, N.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A.; Lodial, S.; Hassoun, H.; Doss, D.; Lunde, L.; Hayes, S.; McKenney, M.; Hande, K.; Lai, L.; Freeman, A.; Dinand, K.; McAlister, C.; Warren, D.; Collins, D.; Esseltine, D.; Amato, A.; Anderson, K. |
| Abstract Title: | A multicenter phase II trial of bortezomib in patients with previously untreated multiple myeloma: Efficacy with manageable toxicity in patients with unexpectedly high rates of baseline peripheral neuropathy |
| Meeting Title: | 47th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 106 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2005 Dec 10-13 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2005-11-01 |
| Start Page: | 716A |
| Language: | English |
| ACCESSION: | WOS:000233426004395 |
| PROVIDER: | wos |
| PUBMED: | 16342400 |
| DOI: | 10.1182/blood.V106.11.2548.2548 |
| Notes: | --- - Meeting Abstract: 2548 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - "1" - "Source: Wos" |
